Programme
Download a printable PDF of the programme overview (PDF)
and the programme in detail (PDF).
View the full list of social events
- 11.00 - 13.00 Registration
- 13.00 - 13.05 Welcome
- 13.05 - 13.30 KN1 President's Opening Lecture
- 13.30 - 14.00 KN2 Melanie Reid, Journalist, The Times and The Sunday Times
- 14.00 - 14.30 KN3 Professor Andrew McIntosh, Chair of Biological Psychiatry, University of Edinburgh
-
14.35 - 15.50
S1 New NICE Guidance for mental health rehabilitation: A unique opportunity to improve care for people with complex psychosis
Chair: Dr Sridevi Kalidindi, CBE, National Clinical Lead for Mental Health Rehabilitation, GIRFT, NHS England and NHS ImprovementNICE guidance for people with complex psychosis and related conditionsProfessor Helen Killaspy, University College LondonAddressing the human cost of disinvestment in rehabilitation servicesCarer Representative, Rehabilitation & Social Executive Committee, Royal College PsychiatristsImprovement methodology for implementing NICE guidance: from teams to whole systemDr Rajesh Mohan, Chair of Rehabilitation Faculty, Royal College of Psychiatrists
-
14.35 - 15.50
S2 Clinical Hypnosis in Medical settings - its role in the management of Functional Disorders and Overlay
Chair: Dr Peter Aitken, Director of Research & Development, Devon Partnership NHS Trust, Honorary Associate Professor, University of Exeter Medical SchoolHypnotherapy for Functional Gastrointestinal DisordersProfessor Peter Whorwell, Consultant Gastroenterologist, University of ManchesterThe Nature of Hypnosis for Dissociative Neurological Symptom DisorderDr Jason Price, Consultant Neuropsychologist, South Tees Hospitals NHS Foundation TrustThe Body keeps the Score. (How to integrate hypnotic techniques into the Liaison Psychiatric service.)Kate Chartres, Nurse Consultant Liaison Psychiatry, Northumberland, Tyne & Wear NHS Foundation Trust
-
14.35 - 15.50
TC1 Treatment Resistant Psychosis 1
Chair: Dr Fiona Gaughran, Lead Consultant, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Reader, Institute of Psychiatry, Psychology and NeuroscienceCannabis and violence: is any association mediated by Paranoia?National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and NeuroscienceTreatment resistant psychosis in children and adolescentsDr Johnny Downs Institute of Psychiatry, Psychology and Neuroscience and Dr Marinos Kyriakopoulos, CAMHS, South London and Maudsley NHS Foundation TrustMechanisms underlying treatment response in schizophreniaProfessor Sukhi Shergill, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience
-
14.35 - 15.50
S3 Leadership development for psychiatrists
Chair: Dr Lenny Cornwall, Consultant Psychiatrist, Tees, Esk & Wear Valleys NHS TrustThe employer perspective – what knowledge and skills are employers looking for?Dr Lenny Cornwall, Consultant Psychiatrist, Tees, Esk & Wear Valleys NHS TrustThe trainee perspective – what do trainees get from leadership training and what can they get?Dr Alex Till, Dr Alex Till, Specialty Registrar in Forensic Psychiatry & Chair of the Psychiatric Trainees Committee 2018-19, Royal College of PsychiatristsThe College perspective – what does the College understand to be the leadership role for psychiatrists and how will the new higher training curricula support this?Dr Helen Crimlisk, Deputy Medical Director, Sheffield Health and Social Care NHS Trust; Associate Registrar,Leadership and Management, Royal College of Psychiatrists
-
14.35 - 15.50
S4 Implications of the ICD-11 classification of personality disorders
Chair: Professor Mike Crawford, Professor in Mental Health Research, Centre for Psychiatry, Imperial College, LondonThe essential elements of the ICD-11 classification of personality disordersProfessor Peter Tyrer, Emeritus Professor of Community Psychiatry, Imperial College, LondonWhere have all the labels gone?: the domain structure of ICD-11 personality disordersProfessor Roger Mulder, Professor of Psychiatry, University of OtagoImplications of ICD-11 personality disorders in clinical practice: an eight-year clinical trialDr Rahil Sanatinia, Research Associate, Centre for Psychiatry, Imperial College, London
- 15.50 - 16.20 Tea
-
16.20 - 17.35
S5 Mental Health Care for Underserved Populations - Ethnic, Racial, and Linguistic Inequalities
Chair: Professor Kenneth R. Kaufman, AM, MD, FRCPsych, DLFAPA, FAES; Professor of Psychiatry, Neurology and Anaesthesiology, Rutgers Robert Wood Johnson Medical School; New Jersey, USA; Visiting Professor, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College LondonEthnic inequalities in severe mental illness: a new approachProfessor Kamaldeep S. Bhui, CBE, MBBS, MSc, MD, FRCPsych; Professor of Cultural Psychiatry & Epidemiology, Centre Lead for Psychiatry, Wolfson Institute of Preventive Medicine, Hon. Consultant Psychiatrist, East London Foundation Trust, Barts & The London School of Medicine & Dentistry, Queen Mary University of LondonUnravelling the complexities of inequalities in mental health care and outcomes for cultural and linguistic minoritiesProfessor Steve Kisely, MD, MSc, PhD, FRCPsych, FRANZCP, FFPH, FAFPHM, FAChAM; Professor, Discipline of Psychiatry, School of Medicine, The University of Queensland, Australia and Professor of Psychiatry, Community Health and Epidemiology, Dalhousie University, CanadaMental health care for the underserved in BrazilProfessor Sara Evans–Lacko, PhD; Associate Professor, Personal Social Services Research Unit (PSSRU), London School of Economics and Political ScienceHealth system strengthening for mental health in low- and middle-income countries: introduction to the Emerald programmeProfessor Mark Jordans, PhD; Professor of Global Child and Adolescent Mental Health, Faculty of Social and Behavioural Sciences, University of Amsterdam, and Director, Research and Development, War Child Holland, The Netherlands; Reader in Child and Adolescent Mental Health in Humanitarian Settings, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
-
16.20 - 17.35
S6 Health anxiety: the silent epidemic that can be treated easily
Chair: Professor Peter Tyrer, Emeritus Professor of Psychiatry, Imperial College, LondonPathological illness worries (health/illness anxiety) in the general population:The DanFunD studyProfessor Per Fink, Head of the Research Clinic for Functional Disorders and Psychosomatics, Aarhus University HospitalMulti-centre randomised controlled trial (RCT) for health anxiety in primary and general hospital care: clinical and economic outcomesProfessor Richard Morriss, Professor of Psychiatry and Community Mental Health, University of NottinghamHealth anxiety and its management in medical settingsProfessor Peter Tyrer, Emeritus Professor of Community Psychiatry, Imperial College, London
-
16.20 - 17.35
TC1 Treatment Resistant Psychosis 2
Chair: Dr Fiona Gaughran, Lead Consultant, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Reader, Institute of Psychiatry, Psychology and NeurosciencePersonalised Psychiatry for Psychosis; preliminary results from the MRC-STRATA ProgrammeProfessor James MacCabe, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and NeuroscienceA fine balance; quality and safe use of clozapineProfessor Dan Siskind, Conjoint Principal Research Fellow, Queensland Brain Institute, University of QueenslandInflammation, Poo and PsychosisProfessor Iris Sommer, Director of Research Institute Brain and Cognition, UMCG, University of Groningen
-
16.20 - 17.35
MC1 Approaches to managing bullying and undermining in the workplace
Chair: Dr Ross Runciman, Chair Psychiatric Trainees' Committee 19/20 - Royal College of PsychiatristsDr Ros Ramsay, Specialist Advisor for the Psychiatry Support ServiceConsultant Psychiatrist/Deputy Medical Director, South London and Maudsley NHS Foundation Trust, National Psychosis Unit - Tony Hillis Unit, Lambeth Hospital/Trust HQ Maudsley HospitalProfessor Dinesh Bhugra, Emeritus Professor of Mental Health and Cultural Diversity at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Past President of the Royal College of Psychiatrists. Past President of the World Psychiatric Association. Past President of the British Medical Association
Dr Alpana Rose - 17.35 - 18.10 KN4 Dr Rob Poole, Consultant Psychiatrist
- 18.10 - 18.45 KN5 Pat Sowa
- 18.45 - 19.30 Welcome Reception
- 8.00 - 9.00 Registration and coffee
- 9.00 - 9.30 KN6 Dr Claire Murdoch, NHS England National Mental Health Director
- 9.30 - 10.00 KN7 Professor Daisy Fancourt, Associate Professor, Wellcome Research Fellow, University College London
-
10.10 - 11.25
S8 Early Life Stress In Severe Affective Disorders: From Neuroscience To Treatment
Chair: Prof Allan H Young, Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College LondonChildhood maltreatment and the physical burden of patients with bipolar disordersProf. Bruno Etain, University Paris Diderot and Assistance Publique des Hopitaux de Paris, FranceTelomere length is associated with childhood trauma experiences in patients with a severe mental disorderDr Monica Aas, NORMENT K.G Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, NorwayHPA axis, Genetic Biomarkers and Early Life Stress impact in Affective disordersDr Mario F P Juruena, Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
-
10.10 - 11.25
TC2 Disorders at the interface of neurology and psychiatry
Chair: Prof Alan Carson, Centre for Clinical Brain Sciences, University of EdinburghNeurological examination for psychiatristsProfessor Adam Zeman, Professor of Cognitive and Behavioural Neurology, University of ExeterCognitive examination beyond the mini mental stateProfessor Adam Zeman, Professor of Cognitive and Behavioural Neurology, University of Exeter
-
10.10 - 11.25
S9 Clinical Update on ADHD across the lifespan: BAP and other guidelines
Chair: Prof Anne Lingford-Hughes, Division of Psychiatry, Imperial College LondonIntroducing ADHD: diagnosis, comorbidities, and neurobiologyDr Samuel Chamberlain, Department of Psychiatry, University of CambridgeHow does ADHD present across the lifespan, and how do services handle it? Findings from the CATCh-uS projectProfessor Tamsin Ford, Department of Psychiatry, University of CambridgeEvidence-based treatment of ADHD in children and adolescentsProf Samuele Cortese, Department of Psychiatry, University of Southampton
-
10.10 - 11.25
S10 Improving services for people with substance use and comorbid mental disorders
Chair: Julia Sinclair, Professor of Addiction Psychiatry, University of Southampton
Fighting The Friendly Foe. Personal Experience of Alcohol Addiction
Diane Goslar, Expert by Experience
Our Invisible Addicts; The changing face of alcohol and drug addiction
Dr Tony Rao, Consultant Old Age Psychiatrists, South London and Maudsley NHS Foundation Trust
Frightened, alone and away from home” Personal experience of drug addiction and co-morbid mental disorder
Rachel Bannister, Expert by Experience -
10.10 - 11.25
S11 Perinatal Suicide: A Global Issue
Chair: Dr Joanne Black, Devon Partnership NHS Trust
Suicidality in the Perinatal Period: A Service-User Perspective
Expert by experience
Suicide in Women with Perinatal Mental Disorders
Dr Karyn Ayre, Section of Women’s Mental Health (SWMH), Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King’s College London and South London and Maudsley NHS Foundation Trust
Perinatal Suicide in Low and Middle-Income Countries
Dr Gertrude Seneviratne, South London and Maudsley NHS Foundation Trust - 11.25 - 11.50 Coffee
-
11.55 - 13.10
S12 Neurobiology and treatment of addictions: from substances to behaviours
Chair: Prof Julia Sinclair, Department of Psychiatry, University of SouthamptonAlcohol use disorder as the archetypal addiction: definitions, neural circuitry, and evidence-based treatmentProf Anne Lingford-Hughes, Division of Psychiatry, Imperial College LondonFrom recreational gambling, to problem gambling, to gambling disorder: how does it progress and when should we intervene?Professor Jon Grant, Department of Psychiatry, University of ChicagoThe role of technology in addictionDr Samuel Chamberlain, Department of Psychiatry, University of Cambridge
-
11.55 - 13.10
TC2 Disorders at the interface of neurology and psychiatry
Chair: Dr Jon Stone, Professor of Neurology, Centre for Clinical Brain Sciences, University of EdinburghCognitive Behavioural Therapy for Dissociative Seizures: the CODES trial outcome dataProfessor of Neuropsychology, Institute of Psychiatry, Psychology and NeuroscienceFunctional cauda equine syndromeDr Ingrid Hoeritzauer, Centre for Clinical Brain Sciences, University of Edinburgh
-
11.55 - 13.10
S13 Maternal Affective Disorders and Neonatal-Infantile development
Chair: Dr Angelika Wieck, Greater Manchester Mental Health NHS Foundation TrustInfluence of maternal depression on foetal growth and neonatal neurobehavioural developmentStress, Psychiatry and Immunology Lab, Department of Psychological Medicine, Kings College London
Review of the evidence regarding the possible association between autism spectrum disorders and in utero SSRI exposureProfessor Ian Jones, Institute of Psychological Medicine and Clinical Neuroscience, Cardiff UniversityPrescription of valproate-containing medicines in women of childbearing potential with psychiatric disorders – is it worth the risk?Professor David Baldwin, Faculty of Medicine, University of Southampton -
11.55 - 13.10
S14 Talking about mental health in the media: platforms, pitfalls, and new directions
Chair: Dr Niall Boyce, Editor, The Lancet PsychiatryScientific journals and social media: an unhappy marriage?The British Journal of PsychiatryFacilitating democratic conversations about mental health research: welcome to the woodland!André Tomlin, The Mental Elf“Why on earth would you want to do that?”: One psychiatrist’s experience of writing for the mainstream mediaDr Mariam Alexander, West London NHS Trust
-
11.55 - 13.10
S15 Trauma, Suicide and Resilience: Lessons from War for Civilian Care
From UK Military Mental Health to Civilian Care: Lessons Across PopulationsProfessor (Sir) Simon Wessely, Institute of Psychiatry, Psychology & Neuroscience, King’s College LondonAustralian Military Mental Health, PTSD and Suicide: How Does Risk Change Over TimeProfessor David Forbes, Phoenix Australia-Centre for Posttraumatic Mental Health, Department of Psychiatry, University of MelbourneTrauma and Stress Disorders in the US Military: Learning more about PTSD, Suicide and TBIProfessor Robert J Ursano, Center for the Study of Traumatic Stress, Uniformed Services University School of Medicine, Bethesda, Maryland USA
- 13.10 - 14.00 Lunch
- 13.35 - 14.00 Rapid fire presentations
- 14.05 - 14.35 KN8 Professor Michael Meaney, Professor of Medicine, McGill University
- 14.35 - 15.05 KN9 Professor David Nutt, Professor of Neuropsychopharmacology, Imperial College London
-
15.10 - 16.25
S16 MDMA, psilocybin, and cannabis - the future sound of psychiatry
Chair: Professor Rupert Mcshane, Oxford Health NHS Foundation Trust and Department of PsychiatryMedical cannabis: The future is greenDr Chloe Sakal, Drug ScienceMDMA therapy for treating alcoholismDr Ben Sessa, Imperial College LondonPsilocybin therapy for treating depressionDr Tim Williams, Clinical Director AWP
-
15.10 - 16.25
TC2 Disorders at the interface of neurology and psychiatry
Chair: Prof Alan Carson, Professor of Neuropsychiatry, Centre for Clinical Brain Sciences, University of EdinburghWhat’s new in prion diseaseReader in Biochemistry, Centre for Clinical Brain Sciences, National CJD Research and Surveillance Unit, University of EdinburghGenetic therapies in neurodegenerative diseasesDr Edward Wild, UCL Huntington’s Disease Centre, University College London
-
15.10 - 16.25
S17 Monoamine oxidase inhibitors (MAOIs) in treatment-resistant depression and anxiety disorders: time for a reconsideration?
Chair: Dr Samuel Chamberlain, Department of Psychiatry, University of CambridgeIs there still a role for MAOI treatment in patients with treatment-resistant depression?Institute of Psychiatry, Psychology and Neuroscience, King’s College London Kings College LondonWhen might MAOI treatment be an option in patients with anxiety (or anxiety-related) disorders?Professor David Baldwin, Faculty of Medicine, University of SouthamptonHow to balance potential benefit and risk when developing guidance on potential MAOI treatment.Dr Antonio Metastasio, Camden and Islington NHS Foundation Trust
-
15.10 - 16.25
S18 Mental Health Law Reform and Human Rights: Can Scotland lead the world in proposed reforms?
Chair: Professor of Mental Health & Capacity Law, Edinburgh Napier UniverstyThe Alternative Review of the Mental Health Act (England): Challenges for Scotland to do betterAkiko Hart, Chief Executive Officer, National Survivor User NetworkWhat could be achieved in the review of Scotland’s act and what should we learn (or not) from other jurisdictions’ Act’s and the English Independent Review?Medical Director, Mental Welfare Commission for ScotlandThe review of the Scottish Mental Health Act: Interim Report and progressColin Mckay, Review Executive Committee Member & Chief Executive, Mental Welfare Commission
-
15.10 - 16.25
MC2 Recognising and treating mental illness in medical students and doctors
Chair: Professor Sir Simon Wessely, Professor of Psychiatry, KCLA psychiatrists experience of his own mental illnessConsultant in Neuropsychiatry, Birmingham and Solihull Mental Health Foundation Trust, Hon. Professor of Neuropsychiatry, University of BirminghamA medical student’s experience of his own mental illnessMr Usama Ali, Medical Student, Imperial College LondonHow medical students and doctors can access help and treatment for mental illnessClare Gerada, MD of NHS Practitioner service
- 16.25 - 16.45 Tea
-
16.50 - 18.05
S19 Adversity and the Brain in Psychosis – new understandings of mechanisms
Chair: Professor Anthony David, Director, UCL Institute of Mental Health, LondonSocial adversity, Salience processing and DopamineDr Rob McCutcheon, Academic Clinical Lecturer, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, KCL, LondonStructural Brain changes mediate the association between environmental risk factors and psychotic experiences in young peopleDr Kate Merritt, Research Fellow, University College LondonSocial stress and Proteomic prediction models for transition to psychosis in the At Risk Mental StateProfessor David Cotter, Professor of Molecular Psychiatry, Royal College of Surgeons in IrelandAdversity and the Brain in Psychosis – future directions for researchProfessor Avi Reichenberg, Professor of Psychiatry and Environment and Public Health, Icahn School of Medicine at Mount Sinai, New York and Reader in Epidemiology, Department of Psychosis Studies Institute of Psychiatry, Psychology and Neuroscience, London
-
16.50 - 18.05
TC2 Disorders at the interface of neurology and psychiatry
Chair: Prof Jon stone, Professor of Neurology, Centre for Clinical Brain Sciences, University of Edinburgh
Do footballers get more dementia?
Daniel Mackay, University of Glasgow
A clinical approach to traumatic brain injury patients
Prof Alan Carson, Centre for Clinical Brain sciences, University of Edinburgh -
16.50 - 18.05
S20 Ketamine: new trial data and use in practice
Chair: Prof Rupert McShane, Oxford Health NHS Foundation Trust and Dept Psychiatry, University of OxfordKetamine to prevent Alcohol RElapse (KARE): an MRC funded study in Exeter and UCLProfessor Celia Morgan, Professor of Psychopharmacology, Exeter UniversityOpen label extension data from an RCT of daily oral esketamine from NetherlandsProf Robert Schoevers, Department of Psychiatry, University of Groningen, NetherlandsUse of ketamine and related antidepressants in UKProf Rupert McShane, Oxford Health NHS Foundation Trust and Dept Psychiatry, University of Oxford
-
16.50 - 18.05
S21 Social Media and Mental Health in Young People
Chair: Nikki Nabavi, University of ManchesterOnline Risks for the Mental Health of Young PeopleDr Jon Goldin, FRCPsych, Consultant Child and Adolescent Psychiatrist, Specialty Lead DCAMH, Joint Training Programme Director, Vice-Chair CAP Faculty, RCPsych, Honorary Senior Lecturer at the Institute of Child HealthNet gains?? Exploring the brighter side of social media and young people’s mental healthDr James Woollard, Chief Clinical Information Officer and Consultant Child and Adolescent Psychiatrist, Oxleas NHS Foundation Trust. National Specialty Advisor in Digital Mental Health, NHS England and ImprovementLived experience of being online and in the public eyeTBC
- 18.10 - 19.00 Film screening and Q and A – Magic Medicine: Can Magic Mushrooms Cure Depression - Professor David Nutt
- 8.00 Registration and coffee
- 8.0 - 9.00 KN10 APA President
- 9.00 - 9.30 KN11
-
9.40 - 10.55
S23 Genetic disorders: applying science in clinical practice
Chair: Dr Kate Lovett, Dean, Royal College of PsychiatristsAlzheimer’s Disease in Down Syndrome: a Genetic Condition with Variable OnsetProf. Andre Strydom, Professor of Intellectual DisabilitiesGenetic Testing in Clinical Practice: Towards a Cross-disciplinary FrameworkConsultant Psychiatrist in Intellectual Disability, Forensic Network Clinical Lead for Intellectual DisabilitiesSingle Gene Disorders: Relevance to Patients, Families, and CliniciansDr Lindsay Mizen, Consultant Psychiatrist West Lothian Community Learning Disability Team, Senior Clinical Research Fellow University of Edinburgh
-
9.40 - 10.55
S24 Dimensional and Categorical Psychopathology in Youth: Cognitive and Brain Imaging Findings
Chair: Prof. Sophia Frangou, Research Chair in Brain Health, University of British Columbia, Canada and Professor of Psychiatry, Icahn School of Medicine at Mount Sinai, USABrain correlates of psychopathology in children growing up in social disadvantaged or enriched environmentsProf. Sophia Frangou, Research Chair in Brain Health, University of British Columbia, Canada and Professor of Psychiatry, Icahn School of Medicine at Mount Sinai, USAThe course of anhedonia in depression: insights from a multi-modal, longitudinal neuroimaging studyDr Argyris Stringaris, Chief, Mood Brain & Development Unit, National Institute of Mental Health and Professor of Clinical Psychiatry, Georgetown University, USATrajectory of brain structural development in young individuals at familial risk of mood disorder?Dr Heather Whalley, Reader in Psychiatry, Division of Psychiatry, University of Edinburgh
-
9.40 - 10.55
S25 Improving quality and reducing variation in mental health services
Chair: Dr Sarah Markham, Visiting Researcher, Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology & NeuroscienceInside the National Institute for Health and Care Excellence: Reflections from a NICE ScholarshipDr. Howard Ryland, NIHR Doctoral Research Fellow, University of Oxford, Honorary Consultant Forensic Psychiatrist, Oxford Health NHS Foundation TrustNo Quality without Equality! Advancing Mental Health Equality to improve outcomes for allDr Shubulade Smith, Consultant Psychiatrist and Senior Lecturer, Clinical Director, Forensic Services, South London and Maudsley NHS Foundation Trust (SLaM) and Clinical Director National Collaborating Centre for Mental Health (NCCMH), Royal College of PsychiatristsGetting It Right First Time in Rehabilitation: A National Programme Supporting Transforming LivesDr Sridevi Kalidindi, Consultant Psychiatrist in Rehabilitation & Recovery SLaM NHS FT, National Clinical Lead, Getting It Right First Time (GIRFT) Mental Health Rehabilitation, NHS England & Innovation (NHSE&I), NHSE Clinical Entrepreneur, NHSE&I and Visiting Senior Clinical Lecturer, Institute of Psychiatry, Psychology and Neuroscience (IOPPN)
-
9.40 - 10.55
S26 Lead us not into error -- wisdom from statistics reviewers
Chair: Eva Petkova, PhD, Professor, New York University Grossman School of Medicine, New York, NY, USA and Senior Researcher, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USAMachine learning for psychiatric research: Current reality and future prospectsMelanie Wall, PhD, Professor, Department of Biostatistics, Mailman School of Public Health and Director of Mental Health Data Science in the Department of Psychiatry, Columbia University Medical Center and the New York State Psychiatric InstituteLatent variables and structural equation modelling for contemporary mental health researchIrini Moustaki, PhD, Professor, London School of Economics & Political ScienceLying with statisticsSteve Kisely, MD, PhD, DMedRes, Professor, Professor, Discipline of Psychiatry, School of Medicine, The University of Queensland
-
9.40 - 10.55
S27 Optimising psychotropic medication: making rational medication decisions
Chair: Professor Angela Hassiotis, UCL Division of Psychiatry and Camden and Islington Foundation NHS TrustThe clinical and ethical imperative to optimise medication useDr Rory Sheehan, University College London and East London NHS Foundation TrustChallenges to making medication decisionsDr Dheeraj Rai, Consultant Senior Lecturer in Psychiatry, University of Bristol
Multi-stakeholder solutions to achieve medication optimisationDr Rohit Shankar MBE, Consultant in Adult Developmental Neuropsychiatry Cornwall Partnership NHS Foundation Trust & Associate Professor (Hon.)/Senior Clinical Lecturer, University of Exeter Medical School - 10.55 - 11.25 Coffee
-
11.30 - 12.45
S28 Can we PREVENT dementia?
Chair: Prof John O’Brien, Department of Psychiatry, University of CambridgeCan we prevent dementia?Prof Craig Ritchie, Centre for Clinical Brain Sciences, University of EdinburghCan imaging detect changes 20 years before dementia onset?Prof John O’Brien, Department of Psychiatry, University of CambridgeVirtual reality as a putative tool for the early diagnosis of dementiaMs Coco Newton, Department of Psychiatry, University of Cambridge
-
11.30 - 12.45
MC3 De-prescribing psychotropic medication – learning from a tale of two countries
Chair: Dr. Ken Courtenay, Chair, Faculty of Psychiatry of Intellectual Disability, Royal College of PsychiatristsThe patient experiencePhillip Wills
The Dutch experienceDr Gerda de Kuijper, MD, intellectual disability physician, Centre for Intellectual Disability and Mental Health GGZ Drenthe, Assen, the Netherlands/senior researcher University Medical Centre Groningen/department psychiatry, the Netherlands
The UK experienceDr Rohit Shankar MBE, FRCPsych Consultant in Adult Developmental Neuropsychiatry Cornwall Partnership NHS Foundation Trust & Associate Professor (Hon.)/Senior Clinical Lecturer University of Exeter Medical School -
11.30 - 12.45
S30 The Changing Landscape of Publishing and Plan S -- Where Should I Publish – A Guide for Students, Trainees, and Junior/Senior Researchers
Chair: Professor Kenneth R. Kaufman, AM, MD, FRCPsych, DLFAPA, FAES; Professor of Psychiatry, Neurology and Anaesthesiology, Rutgers Robert Wood Johnson Medical School; New Jersey, USA; Visiting Professor, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London; London, UKGetting published: practice tips for students, trainees, and tenacious researchersProfessor Kamaldeep S. Bhui, CBE, MBBS, MSc, MD, FRCPsych; Professor of Cultural Psychiatry & Epidemiology, Centre Lead for Psychiatry, Wolfson Institute of Preventive Medicine, Hon. Consultant Psychiatrist, East London Foundation Trust, Barts & The London School of Medicine & Dentistry, Queen Mary University of London
Predatory journals and dubious publishers: how to avoid being their preyProfessor Steve Kisely, MD, MSc, PhD, FRCPsych, FRANZCP, FFPH, FAFPHM, FAChAM; Professor, Discipline of Psychiatry, School of Medicine, The University of Queensland, Australia and Professor of Psychiatry, Community Health and Epidemiology, Dalhousie University, Canada; Brisbane, Australia
RCPsych – Cambridge University Press portfolio: an update on quality open access journalsProfessor Kenneth R. Kaufman, AM, MD, FRCPsych, DLFAPA, FAES; Professor of Psychiatry, Neurology and Anaesthesiology, Rutgers Robert Wood Johnson Medical School; New Jersey, USA; Visiting Professor, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London
The changing landscape of publishing and Plan SMs. Ann Avouris, BA; Executive Publisher, Journals at Cambridge University Press; New York, USA -
11.30 - 12.45
S31 Psychotherapy Practice: UK and US Perspectives
Chair: Dr Ken Busch, Assembly of the American Psychiatric AssociationPsychotherapy training in psychiatry in the UK and the USDr Jessica Yakeley, Tavistock and Portman NHS Foundation Trust, London
The Royal College of Psychiatrists Medical Student Psychotherapy Scheme StrategyDr Sarah Majid, Tavistock and Portman NHS Foundation Trust, London
Psychotherapy with the LGBT population in the USDr James R. Batterson, UMKC School of Medicine, Immediate Past Speaker, Assembly of the American Psychiatric Association
Comparing and contrasting perspectives on psychotherapy in psychiatry from both sides of the AtlanticDr Joseph Napoli, Speaker-Elect, Assembly of the American Psychiatric Association -
11.35 - 13.40
S32 Research training: a session for medical students, FY doctors, and psychiatry trainees (followed by a networking lunch)
Chair: Dr Kate Lovett, Royal College of PsychiatristsThe whys and wherefores of research training.Prof Tamsin Ford, Department of Psychiatry, University of Cambridge
How to publish: (crystal clear) points means prizes. Writing abstracts and postersDr Sam Chamberlain, Department of Psychiatry, University of Cambridge
Navigating the submission maze: what do publishers look for in a good paper?Dr Niall Boyce, Editor-in-Chief of The Lancet Psychiatry - 12.45 - 13.40 Lunch
- 13.20 - 13.45 Rapid fire presentations
- 13.50 - 14.00 KN12 Chief Executive's Address - Paul Rees, Chief Executive of the Royal College of Psychiatrists
- 14.00 - 14.30 KN13 Professor Alan Carson, Consultant Neuropsychiatrist and Honorary Clinical Senior Lecturer
-
14.30 - 15.45
S33 Recent advances in dementia
Chair: Prof John O’Brien, Department of Psychiatry, University of Cambridge
Watch your step: Potential clinical applications of gait analysis in dementiaDr Ríona Mc Ardle, Newcastle University
New insights from Epigenetics: DNA methylation alterations in Lewy Body DementiaDr Leo Chouliaras, Department of Psychiatry, University of Cambridge
Improving the diagnosis and management of Lewy body dementia: The DIAMOND-Lewy studyProf John O’Brien, Department of Psychiatry, University of Cambridge -
14.30 - 15.45
S35 A National Quality Improvement Collaborative: Reducing Restrictive Practice
Chair: Tom Ayers, National Collaborating Centre for Mental Health
Saiqa Akhtar, NCCMH, Quality Improvement Coach
Kate Lorrimer, NCCMH, Quality Improvement Coach -
14.30 - 15.45
MC4 Reconceptualising “Treatment Resistant Depression” as “Difficult to Treat Depression”: Why is this important and what are the implications for patient management?
Chair: Dr Andreas Papadopoulos, Somerset Partnership NHS Foundation Trust
Why “difficult to treat depression” rather than “treatment resistant depression”Dr Koen Demyttenaere, University Psychiatric Center KU Leuven
How to manage difficult to treat depressionProfessor Hamish McAllister-Williams, Newcastle University
Treatment of other sleep problemsTBC - 15.45 - 16.10 Tea
-
16.10 - 17.25
MC5 Attention deficit hyperactivity disorder (ADHD) in university students
Chair: Philip Asherson, King’s College London
Assessment, research findings & reasonable adjustmentsJane Sedgwick-Müller, King’s College London
Pharmacological treatment of ADHDPhilip Asherson, King’s College London
Service models & management of co-morbidityUlrich Müller-Sedgwick, Barnet Enfield & Haringey Mental Health NHS Trust & University of Cambridge -
16.10 - 17.25
S37 Improving sexual safety in mental health inpatient settings
Chair: Vanessa Ford, South West London and St George’s Mental Health NHS Trust
Sally Smith
Jessica Barrett, Lead Researcher and Developer, National Collaborating Centre for Mental Health
Improving sexual safety in mental health inpatient settings: A National Quality Improvement CollaborativeDr Matthew Milarski, Quality Improvement Coach, National Collaborating Centre for Mental Health -
16.10 - 17.25
S38 Personalised Training - a guide for trainers and trainees
Chair: Dr Chris O’Loughlin, Head of School East of England
Taking the lead – the trainee’s role in personalised trainingRoyal Navy – Institute of Naval Medicine, South London & Maudsley NHS Foundation Trust
Supporting International Graduates – using personalised training to address differential attainmentDr Saadia Alvi, Speciality Training Registrar, South Yorkshire.
International Medical Graduates representative to Royal CollegeDr Charlotte Blewett Consultant Psychiatrist in Student Mental Health and Old Age Psychiatry, Sheffield Health and Social Care NHS Foundation Trust -
16.10 - 17.25
S39 Addressing substance misuse in LGBT+ communities
Chair: Dr Maire Cooney, Consultant in Rehabilitation Psychiatry Grater Clyde and Glasgow NHS Trust
The use of novel stimulants in the general population and LGBT+ communityDerek Tracy, King's College London
The social context of drinking amongst LGBT+ people in ScotlandCarol Emslie, Glasgow Caledonian University
Understanding the pleasure and benefits of drug useIan Hamilton, University of York - 17.30 - 18.45 AGM and Presentation Ceremony
- 8.00 - 9.00 Registration and coffee
- 9.00 - 9.30 KN14 Professor Anil Seth, Professor of Cognitive and Computational Neuroscience, University of Sussex
-
9.40 - 10.55
MC6 Neurmodulation for mental illness: An update
Chair: Professor Eileen Joyce, Professor of Neuropsychiatry, UCL Queen Square Institute of Neurology
Transcranial Direct Current Stimulation (TDCS) for Mental IllnessDr Eduardo Cinosi, Consultant Psychiatrist, Hertfordshire Partnership University NHS Foundation Trust
Repetitive Transcranial Magnetic Stimulation (rTMS) for Mental IllnessProfessor Richard Morriss, Professor of Psychiatry & Community Mental Health Faculty of Medicine & Health Sciences, University of Nottingham
Deep Brain Stimulation (DBS) for Severe Mental IllnessProfessor Eileen Joyce, Professor of Neuropsychiatry, UCL Queen Square Institute of Neurology -
9.40 - 10.55
S40 Cardiac and metabolic parameters and antipsychotic drug treatment
Chair: Professor David Baldwin, Faculty of Medicine, University of Southampton
Schizophrenia is associated with adverse changes in cardiac structure independent of conventional cardio-metabolic risk factors: a cardiac MR imaging studyDr Emanuele Osimo, Imperial College London, Hammersmith Campus, London; University of Cambridge, Department of Psychiatry; Cambridgeshire and Peterborough NHS Foundation Trust
Comparative effects of 18 antipsychotics on metabolic function in schizophrenia: a network meta-analysisDr Toby Pillinger, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College, London
Modification of lifestyle risk factors in patients undergoing antipsychotic drug treatmentDr Adrian Heald, School of Medicine, University of Manchester -
9.40 - 10.55
S41 Understanding and managing clinical risk for women with severe mental illness during pregnancy and post-partum
Chair: Dr Liz McDonald, Clinical Lead for PMH Bursary Programme, RCPsych, Visiting Lecturer, Tavistock and Portman Trust, Hon. Consultant, ELFT
Bipolar disorder and Postpartum Psychosis – can we individualise risk?Professor Ian Jones, Cardiff University
Schizophrenia in women: what risk issues need to be considered in the perinatal period?Dr Liz McDonald, Clinical Lead for PMH Bursary Programme, RCPsych, Visiting Lecturer, Tavistock and Portman Trust, Hon. Consultant, ELFT
Reducing risk of maternal suicide: lessons from the Confidential Enquiries into Maternal DeathsDr Roch Cantwell, Consultant Perinatal Psychiatrist, Lead Clinician, Perinatal Mental Health Network Scotland -
9.40 - 10.55
S42 Lessons from volunteering in Humanitarian Psychiatry in conflict & disaster zones
Chair: Dr Sophie Thomson, Chair of VIPSIG at RCPsych
What is humanitarian psychiatry?Dr Lynne Jones, FXB Center for Health and Human rights, Harvard University, Honorary consultant, Cornwall Partnership foundation Trust; South London and Maudsley Foundation trust
Sustainable Humanitarian Psychiatry: Mental Health in Primary CareDr Peter Hughes, South West London and St Georges Mental Health NHS Trust
Live demonstration of Distant Volunteering: Mental Health Care for Rohingyas in BangladeshDr Anis Ahmed, Birmingham and Solihull Mental Health NHS Foundation Trust -
9.40 - 10.55
MC7 Frequent Attendance at Emergency Departments with Mental Health Needs – What Helps, What’s it Like and Who Can Help?”
Chair: Dr Catherine Hayhurst, Consultant in Emergency Medicine, Cambridge University Hospitals NHS Foundation Trust and Chair of Mental Health Subcommittee, Royal College of Emergency Medicine
What’s the Evidence? An Overview of Research on Frequent AttendanceDr Alex Thomson, Consultant Liaison Psychiatrist, Central and North West London NHS Foundation Trust and Committee Member, RCPsych Liaison Psychiatry Faculty Executive Committee
What’s it Like? The Experience of Attending Emergency Departments Frequently with Mental Health NeedsDr Emma McAllister, Lived Experience Advisor, UK and Patient Representative, RCPsych Liaison Psychiatry Faculty Executive Committee
What Helps? Top Tips for Achieving a Service with ImpactMs Rhian Monteith, Advanced Paramedic and Specialist Advisor, NHS RightCare - 10.55 - 11.20 Coffee
-
11.25 - 12.40
S43 Onset of effect of lithium in affective disorders
Chair: Professor David Baldwin, Faculty of Medicine, University of Southampton
Lithium augmentation: tortoise or hare?Dr David Cousins, MRC Clinician Scientist, Newcastle University
Review of the evidence regarding reduction of suicide during treatment with lithiumDr Ute Lewitzka, Department of Psychiatry and Psychotherapy, University Hospital C.G. Carus, Dresden
Timing of onset of relapse prevention with lithium in bipolar disorder: evidence from randomised controlled trialsDr Matthew Taylor, Department of Psychiatry, University of Oxford -
11.25 - 12.40
S44 Advances in treatment of complex mood disorders
Chair: Professor Allan Young, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
Next Generation Rapid Acting AntidepressantsCarlos A. Zarate, Jr., M.D, National Institute of Mental Health
An Update on Pharmacological Augmentation Strategies for Major Depressive DisorderProfessor Anthony Cleare, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
Is transcranial direct current stimulation (tDCS) a treatment for depression?Professor Cynthia Fu, University of East London, Centre for Affective Disorders, IoPPN, King's College London, South London and Maudsley NHS Foundation Trust -
11.25 - 12.40
S45 How to be both: Psychiatrists lived experience of mental illness
Chair: Dr Cate Bailey, Fellow in Medical Education, East London Foundation Trust, Barts and the London Medical School and Queen Mary University and Dr Juliette Brown, Consultant Psychiatrist, East London Foundation Trust
Occupational and counselling psychologist and the founder of Career Planning for Doctors/Dentists
Consultant psychiatrist in addictions working in Edinburgh and committee member for the RCPsych Psychiatrists’ Advice Service.
Psychiatrist, therapist, trainer, coach and speaker who specialises in doctors’ wellbeing and founded “The Joyful Doctor”. -
11.25 - 12.40
MC8 Clinical Neuropsychiatry of Acquired Brain Injury and Neurorehabilitation
Chair: Dr Mark Paramlall, Consultant Neuropsychiatrist in Neurorehabilitation, North Bristol NHS Foundation Trust, Frenchay Brain Injury Rehabilitation Centre
The Neuropsychiatry of StrokeDr Michael Dilley, Consultant Neuropsychiatrist in Neurorehabilitation, Clinical Director & Programme Board Chair, South London Neurosciences ODN, Wolfson Neurorehabilitation Services, St George's University Hospitals NHS Foundation Trust
Neuropsychiatry in a Cognitive Neurorehabitation ServiceDr Stefania Bruno, Consultant Neuropsychiatrist and Medical Director Blackheath Brain Injury Rehabilitation Centre
Neuropsychiatry in a Physical Neurorehabilitation ServiceDr Himanshu Tyagi, Consultant Neuropsychiatrist in Neurorehabilitation and Medical Psychotherapist (CBT), Neurorehabilitation Unit (NRU), National Hospital for Neurology and Neurosurgery - 12.40 - 13.35 Lunch
- 13.10 - 13.35 Rapid fire presentations
- 13.40 - 14.10 KN15 Professor Helen Minnis, Professor of Child and Adolescent Psychiatry, University of Glasgow
- 14.10 - 14.40 KN16 Professor Sophie Frangou, Professor of Psychiatry, Icahn School of Medicine, Mount Sinai
-
14.45 - 16.00
MC9 PsychED: Connecting Psychiatrists with Neuroscience - a masterclass in medical education
Chair: Dr Angharad de Cates, Wellcome Trust Clinical Doctoral Fellow, Department of Psychiatry, University of Oxford & Honorary Specialty Registrar, Oxford Health NHS FT
Spreading the wordDr S. George Morris, Senior Clinical Teaching Fellow, Avon and Wiltshire Mental Health Partnership NHS Trust and Dr Gabrielle Churchhouse, SAS Doctor, Avon and Wiltshire Mental Health Partnership NHS Trust
Overcoming obstaclesDr Jack Underwood, Wellcome Trust GW-CAT Clinical Research Fellow, Cardiff University and Dr Cinzia Giuntoli, CT3 NHS Greater Glasgow and Clyde
Learning by exampleDr Gareth Cuttle, Project Manager - Gatsby/Wellcome Neuroscience Project, Royal College of Psychiatrists -
14.45 - 16.00
S47 Management of sleep disorders: A review of the updated British Association for Psychopharmacology Guidelines
Chair: Professor Hamish McAllister-Williams, Newcastle University
Assessment of sleep problemsDr Kirstie Anderson, Newcastle upon Tyne Hospitals NHS Foundation Trust
Treatment of insomniaDr Sue Wilson, Imperial College London
Treatment of other sleep problemsDr Hugh Selsick, The Royal London Hospital for Integrated Medicine -
14.45 - 16.00
S48 Complex journeys from hospital to community
Chair: Prof. Wendy Burn, President, Royal College of Psychiatrists
Has Transforming Care transformed people’s lives?Dr Ken Courtenay, Chair, Faculty of Psychiatry of Intellectual Disability, Royal College of Psychiatrists
A family’s experience of hospital care and community aspirationMary Busk, mother and Family Carer Adviser NHS England
Safe and sustainable transitions to community for vulnerable adultsDr Rajesh Mohan, Consultant Psychiatrist and Chair, Faculty Social and Rehabilitation Psychiatry, Royal College of Psychiatrists -
14.45 - 16.00
S49 Money and mental health - keeping up with a rapidly changing policy environment
Chair: Dr Billy Boland, Hertfordshire Partnership University NHS Foundation Trust and Chair, Faculty of General Adult Psychiatry, Royal College of Psychiatrists
Money and Mental Health - the evidence and changing policy environmentKatie Alpin, Interim Chief Executive, The Money and Mental Health Policy Institute
Money and Mental Health - insights from the latest researchDame Professor Til Wykes, Professor and Vice Dean Institute of Psychiatry, Psychology and Neuroscience, King’s College London
Money and Mental Health - a personal perspectiveLee Brookes, Expert by Experience -
14.45 - 16.00
S50 Towards sustainable and scalable mental health services in Africa
Chair: Prof Petrus J de Vries, Division of Child & Adolescent Psychiatry, University of Cape Town, Cape Town, South Africa
A retrospective case review of long-acting second generation injectable antipsychotics for the treatment of adults with schizophrenia in KenyaDr Catherine Syengo-Mutisya, Consultant Psychiatrist, Nairobi, Kenya
Education and training in psychiatry in low-resource environments – the story of Sierra LeoneDr Abdul Jalloh, Specialist Psychiatrist and Lecturer, Department of Internal Medicine, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone
Why we have to think differently about intervention research for autism and other neurodevelopmental disabilities in AfricaProf Petrus J de Vries, Division of Child & Adolescent Psychiatry, University of Cape Town, Cape Town, South Africa - 16.00 - 16.20 Tea
-
16.25 - 17.40
S51 Neurofeedback, biofeedback and body-contingent approaches to affective and neuropsychiatric symptom management: New neuroscience and clinical applications
Chair: Prof Hugo Critchley, Brighton and Sussex Medical School
Autonomic biofeedback in management of neuropsychiatric conditionsDr Yoko Nagai, Brighton and Sussex Medical School
Applications of real-time functional magnetic resonance imaging to alleviation of psychological symptomsProfessor David Linden, Maastricht University
Harnessing physiology in anxiety managementDr Cristina Ottaviani, Sapienza University of Rome -
16.25 - 17.40
S52 Rhythm and Blues: advances in understanding and treatment of Bipolar Disorders
Chair: Professor Allan Young, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
Professor Argyris Stringaris, Chief, Mood Brain & Development Unit (MBDU), National Institute of Mental Health, USA
Neurobiology and treatments for maniaDr Sameer Jauhar, Institute of Psychiatry, Psychology & Neuroscience, King's College London
Dissecting bipolar disorder using clinical and mobile assessmentsProfessor Kathleen Ries Merikangas, Ph.D., Senior Investigator & Chief, Genetic Epidemiology Research Unit -
16.25 - 17.40
S54 Mental Health Legislation and People with Intellectual Disability and Autism: An International Perspective
Chair: Dr Adrian James, President Elect of the Royal College of Psychiatrists
Intellectual Disability and Autism-a challenge to Mental Health Legislation
Dr Ken Courtenay, Chair, Royal College of Psychiatrists, Faculty of Psychiatry of Intellectual Disability
The experience of 25 years of excluding people with Intellectual Disability from Mental Health legislation in New Zealand
Dr Mhairi Duff, Auckland Regional Forensic Mental Health Services, New Zealand
Scotland's independent review of learning disability and autism in the Mental Health Act: a human rights based approach
Dr Simon Webster, former Secretary to the independent review of learning disability and autism in Scotland’s Mental Health Act, Mental Welfare Commission for Scotland -
16.25 - 17.40
S55 Flumazenil the GABA-A/benzodiazepine antagonist for treatment of conditions related to exogenous and endogenous benzodiazepines
Chair: Dr Fergus Law, Consultant Psychiatrist in Substance Misuse and Clinical Lead Yeldall Manor
The clinical use of Flumazenil in the Management of Benzodiazepine dependence and associated Anxiety DisordersProfessor Gary K Hulse, Professor of Psychiatry, Sir Charles Gairdner Hospital and Division of Psychiatry, University of Western Australia
European experience in the use of Flumazenil infusions to treat 1400 patients with high dose benzodiazepine dependenceDr Fabio Lugoboni, Chief of Addiction Unit, Division of Internal Medicine, Azienda Ospedaliera Universitaria Integrata Verona, Verona
Clinical experience in the use of the Flumazenil infusions and implant to treat conditions thought to be associated with high endogenous benzodiazepines, including idiopathic hypersomnia, narcolepsy without cataplexy and the late luteal menstral phaseDr George O’Neil, Associate Professor University of Western Australia, and Medical Director Fresh Start Clinic, Perth, Western Australia